193 related articles for article (PubMed ID: 17046829)
1. Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.
Li W; Marshall C; Mei L; Gelfand J; Seykora JT
J Biol Chem; 2007 Jan; 282(2):1161-9. PubMed ID: 17046829
[TBL] [Abstract][Full Text] [Related]
2. Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.
Zhao L; Li W; Marshall C; Griffin T; Hanson M; Hick R; Dentchev T; Williams E; Werth A; Miller C; Bashir H; Pear W; Seykora JT
Cancer Res; 2009 Dec; 69(24):9439-47. PubMed ID: 19934324
[TBL] [Abstract][Full Text] [Related]
3. 'Srcasm: a novel Src activating and signaling molecule.
Seykora JT; Mei L; Dotto GP; Stein PL
J Biol Chem; 2002 Jan; 277(4):2812-22. PubMed ID: 11711534
[TBL] [Abstract][Full Text] [Related]
4. Srcasm modulates EGF and Src-kinase signaling in keratinocytes.
Li W; Marshall C; Mei L; Dzubow L; Schmults C; Dans M; Seykora J
J Biol Chem; 2005 Feb; 280(7):6036-46. PubMed ID: 15579470
[TBL] [Abstract][Full Text] [Related]
5. Srcasm overexpression in psoriasis-insights into pathogenesis.
Pulitzer M; Li W; Hanson M; Singh F; Elenitsas R; Gelfand JM; VanVoorhees A; Seykora JT
J Cutan Pathol; 2007 Feb; 34(2):160-5. PubMed ID: 17244028
[TBL] [Abstract][Full Text] [Related]
6. Epidermal hyperplasia induced by Raf-MAPK signaling requires Stat3 activation.
Tarutani M; Nakajima K; Takaishi M; Ohko K; Sano S
J Dermatol Sci; 2013 Nov; 72(2):110-5. PubMed ID: 23870655
[TBL] [Abstract][Full Text] [Related]
7. Defective thymocyte maturation by transgenic expression of a truncated form of the T lymphocyte adapter molecule and Fyn substrate, Sin.
Donlin LT; Roman CA; Adlam M; Regelmann AG; Alexandropoulos K
J Immunol; 2002 Dec; 169(12):6900-9. PubMed ID: 12471123
[TBL] [Abstract][Full Text] [Related]
8. Decreased Srcasm expression in hyperproliferative cutaneous lesions.
Meulener MC; Ayli EE; Elenitsas R; Seykora JT
J Cutan Pathol; 2009 Mar; 36(3):291-5. PubMed ID: 19220627
[TBL] [Abstract][Full Text] [Related]
9. Src family kinases are required for integrin but not PDGFR signal transduction.
Klinghoffer RA; Sachsenmaier C; Cooper JA; Soriano P
EMBO J; 1999 May; 18(9):2459-71. PubMed ID: 10228160
[TBL] [Abstract][Full Text] [Related]
10. Src family kinases Fyn and Lyn are constitutively activated and mediate plasmacytoid dendritic cell responses.
Dallari S; Macal M; Loureiro ME; Jo Y; Swanson L; Hesser C; Ghosh P; Zuniga EI
Nat Commun; 2017 Apr; 8():14830. PubMed ID: 28368000
[TBL] [Abstract][Full Text] [Related]
11. Activation of c-Src and Fyn kinases by protein-tyrosine phosphatase RPTPalpha is substrate-specific and compatible with lipid raft localization.
Vacaresse N; Møller B; Danielsen EM; Okada M; Sap J
J Biol Chem; 2008 Dec; 283(51):35815-24. PubMed ID: 18948260
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529.
Kang S; Dong S; Guo A; Ruan H; Lonial S; Khoury HJ; Gu TL; Chen J
J Biol Chem; 2008 Feb; 283(8):4652-7. PubMed ID: 18156174
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
[TBL] [Abstract][Full Text] [Related]
14. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
[TBL] [Abstract][Full Text] [Related]
15. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.
Lu KV; Zhu S; Cvrljevic A; Huang TT; Sarkaria S; Ahkavan D; Dang J; Dinca EB; Plaisier SB; Oderberg I; Lee Y; Chen Z; Caldwell JS; Xie Y; Loo JA; Seligson D; Chakravari A; Lee FY; Weinmann R; Cloughesy TF; Nelson SF; Bergers G; Graeber T; Furnari FB; James CD; Cavenee WK; Johns TG; Mischel PS
Cancer Res; 2009 Sep; 69(17):6889-98. PubMed ID: 19690143
[TBL] [Abstract][Full Text] [Related]
16. Fyn deficiency attenuates renal fibrosis by inhibition of phospho-STAT3.
Seo HY; Jeon JH; Jung YA; Jung GS; Lee EJ; Choi YK; Park KG; Choe MS; Jang BK; Kim MK; Lee IK
Kidney Int; 2016 Dec; 90(6):1285-1297. PubMed ID: 27616741
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45.
Mason LH; Willette-Brown J; Taylor LS; McVicar DW
J Immunol; 2006 Jun; 176(11):6615-23. PubMed ID: 16709819
[TBL] [Abstract][Full Text] [Related]
18. Src family kinase-independent signal transduction and gene induction by leukemia inhibitory factor.
Laszlo GS; Nathanson NM
J Biol Chem; 2003 Jul; 278(30):27750-7. PubMed ID: 12764151
[TBL] [Abstract][Full Text] [Related]
19. The focal adhesion kinase Pyk2 links Ca2+ signalling to Src family kinase activation and protein tyrosine phosphorylation in thrombin-stimulated platelets.
Canobbio I; Cipolla L; Guidetti GF; Manganaro D; Visconte C; Kim S; Okigaki M; Falasca M; Kunapuli SP; Torti M
Biochem J; 2015 Jul; 469(2):199-210. PubMed ID: 25967238
[TBL] [Abstract][Full Text] [Related]
20. Src family kinases are required for prolactin induction of cell proliferation.
Fresno Vara JA; Cáceres MA; Silva A; Martín-Pérez J
Mol Biol Cell; 2001 Jul; 12(7):2171-83. PubMed ID: 11452011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
